<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OALibJ</journal-id><journal-title-group><journal-title>Open Access Library Journal</journal-title></journal-title-group><issn pub-type="epub">2333-9705</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/oalib.1103986</article-id><article-id pub-id-type="publisher-id">OALibJ-82586</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Business&amp;Economics</subject><subject> Chemistry&amp;Materials Science</subject><subject> Computer Science&amp;Communications</subject><subject> Earth&amp;Environmental Sciences</subject><subject> Engineering</subject><subject> Medicine&amp;Healthcare</subject><subject> Physics&amp;Mathematics</subject><subject> Social Sciences&amp;Humanities</subject></subj-group></article-categories><title-group><article-title>
 
 
  Higher Complication Rate Following Hip Fractures in Uremic Patients Undergoing Maintenance Hemodialysis: A Cohort Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yi-Hsun</surname><given-names>Yu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yung-Heng</surname><given-names>Hsu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ying-Chao</surname><given-names>Chou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>I-Chuan</surname><given-names>Tseng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wen-Lin</surname><given-names>Yeh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chi-Chung</surname><given-names>Wu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Division of Orthopedic Traumatology, Department of Orthopedic Surgery, Musculoskeletal Research Center, Chang Gung Memorial Hospital, Taiwan</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>02</month><year>2018</year></pub-date><volume>05</volume><issue>02</issue><fpage>1</fpage><lpage>10</lpage><history><date date-type="received"><day>28,</day>	<month>September</month>	<year>2017</year></date><date date-type="rev-recd"><day>20,</day>	<month>February</month>	<year>2018</year>	</date><date date-type="accepted"><day>23,</day>	<month>February</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  The current study retrospectively reviewed the surgical outcomes following hip fractures in uremic patients undergoing long-term hemodialysis and compared the results with those of geriatric patients with osteoporotic hip fractures during 1-year period.
  <b style="line-height:1.5;text-align:justify;white-space:normal;"> </b>
  Thirteen complications occurred among the 21 uremic patients who underwent surgical intervention for a hip fracture. Two complications were related to the failure of osteosynthesis procedures after femoral neck fractures. While comparing perioperative parameters between the 2 groups, patients in the uremic group had younger age, more comorbidities, lower preoperative hem
  oglobin levels and platelet counts, and an increased requirement of perioperative blood transfusion. Statistical analysis revealed a significant increase in incidence of postoperative complications in the uremic patients; however, the incidence of surgery-related complications was unchanged. In conclusion, the present study shows that the incidence of perioperative complications in hip fracture surgeries is higher in uremic patients than those in geriatric hip fractures, mainly resulting from their comorbidities. In addition, we recommend hip prosthesis replacement surgery for femoral neck fractures in uremic patients due to the high rate of implant failure.
 
</p></abstract><kwd-group><kwd>End-Stage Renal Disease</kwd><kwd> Uremia</kwd><kwd> Hip Fracture</kwd><kwd> Osteosynthesis Surgery</kwd><kwd> Post-operative Complication</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>With the advances in hemodialysis treatment, patients with end-stage renal disease (ESRD) now have a longer survival time and a better quality of life. The mineral and endocrine disturbances that occur with long-term hemodialysis alter skeletal metabolism and contribute to fractures [<xref ref-type="bibr" rid="scirp.82586-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref3">3</xref>] . Additionally, the down-regulation of osteoblast activity as a result of renal osteodystrophy impairs fracture healing in patients with ESRD [<xref ref-type="bibr" rid="scirp.82586-ref4">4</xref>] . The majority of orthopedic fractures in uremic patients are lower limb fractures, especially hip fractures [<xref ref-type="bibr" rid="scirp.82586-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref8">8</xref>] . Hip fractures in uremic patients are associated with high morbidity and mortality, with rates 17 - 20 times higher than those of patients with hip fracture in the general population [<xref ref-type="bibr" rid="scirp.82586-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref9">9</xref>] . The rate of postoperative complications following surgical repair of hip fractures in the ESRD population is also significantly increased [<xref ref-type="bibr" rid="scirp.82586-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref11">11</xref>] .</p><p>Another population of patients with increased incidence of hip fracture is the geriatric population. Surgical repair for geriatric osteoporotic hip fractures remains a challenge for orthopedic surgeons. Poor bone quality leads to a fixation dilemma, and comorbidities in the elderly may negatively affect surgical outcomes [<xref ref-type="bibr" rid="scirp.82586-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref15">15</xref>] . A similar predicament exists in uremic patients. In ESRD patients with hip fractures, an increased rate of complications and a higher mortality rate after index surgery have been reported in the literature [<xref ref-type="bibr" rid="scirp.82586-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref16">16</xref>] . However, little evidence exists comparing the complications, morbidity, and mortality following surgical repair of hip fractures between uremic and geriatric patients.</p><p>The purpose of the present study was to review the surgical outcomes following hip fracture repairs in uremic patients undergoing maintenance hemodialysis. In addition, we compared the results in this specific population with those of non-uremic patients with osteoporotic hip fractures and with a minimum of 12 months postoperative follow-up.</p></sec><sec id="s2"><title>2. Materials and Methods</title><p>We retrospectively collected patient data between January and December 2013 from the Trauma Registration System in Chang Gung Memorial Hospital, a level one trauma center in northern Taiwan. We only included patients with uremia and hip fractures (femoral neck and femoral intertrochanteric fractures) who underwent maintenance hemodialysis during the study period and before surgery. Four uremic patients with hip fractures were unable to tolerate anesthesia and surgery and were excluded from the data analysis. Patients undergoing peritoneal dialysis for chronic renal failure rather than hemodialysis were also excluded. In addition, uremic patients with poly trauma and multiple fractures were excluded. In total, 21 patients met the inclusion criteria and were studied.</p><p>During the same one year review period, we identified 458 consecutive patients from the same database with normal renal function, who underwent surgery for hip fractures. Patients aged less than 60 years were excluded, according to the definition of elderly from the World Health Organization. Patients with high-energy trauma, fractures in more than two locations, and poly trauma with more than one major organ injury were also excluded. This was considered necessary as multiple fractures or poly trauma could have confounded the outcome evaluation. Following the exclusion process, 309 geriatric patients with hip fractures were included as the normal control group.</p><p>The patient data were recorded prospectively and analyzed retrospectively. The preoperative clinical variables were recorded, including demographic data and laboratory data. The laboratory data included serum white blood cell count, hemoglobin level, platelet count, blood urea nitrogen level, creatinine level, estimated creatinine clearance rate, and prothrombin time. Prothrombin time was documented using the international normalized ratio. The volume of blood loss intraoperatively, the need for blood transfusion during the surgery and perioperative complications were also recorded. Blood transfusions were documented as packed red blood cells (PRBC) and fresh frozen plasma (FFP). The need for transfusion was determined using clinical data, including a postoperative hemoglobin level less than 10 g/dL in the control group, a loss of 15% of total blood volume, and signs of tachycardia or hypotension during or after surgery.</p><p>A “complication” in the current study was defined as any additional problems arising after the index surgery beyond the surgeon’s expectation, regardless of whether or not the problem was directly related to the surgery. Principal complications related to the hip fracture surgery included the loss of reduction and fixation of the fracture, iatrogenic nerve or vessel injury during the surgery, dislocation of the hip joint after prosthesis replacement, surgical site infection, and loosening of implants. Additional medical or surgical treatments related the patients’ comorbidities were also considered complications.</p><p>The statistical analysis was conducted using SPSS 18.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were presented as the mean and standard deviation. We compared the preoperative and perioperative variables between the study and control groups using a parametric t-test and nonparametric Mann-Whitney U-test. Categorical variables were reported as the frequency, and we compared the two groups using a parametric chi-square test. A two-tailed P-value of 0.05 was considered significant.</p></sec><sec id="s3"><title>3. Results</title><p>Among the 21 uremic patients, one patient died of pneumonia and sepsis during the 12-month follow-up. Overall, there were 13 complications (complication rate: 61.9%) during the 12 months following surgery. Eight complications were in patients with femoral neck fracture and five were in patients with femoral intertrochanteric fracture. In patients with femoral neck fracture, two complications were directly related to the failure of osteosynthesis surgery, whereas no surgery-related complications were seen in the patients who underwent prosthesis replacement surgery. In patients with femoral intertrochanteric fracture, all complications were directly related to preexisting medical comorbidities. <xref ref-type="table" rid="table1">Table 1</xref> summarizes the complications and required treatments for patients in the uremic group.</p><p><xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="table" rid="table3">Table 3</xref> show the demographic data, including patient age and sex, as well as perioperative data, including blood test results and American Society of Anesthesiologists (ASA) classification of both the study and control groups. The uremic patients were significantly younger (69.9 &#177; 8.5 years) than those in the control group (78.7 &#177; 10.5 years) (P &lt; 0.001, t-test). The total number of the underlying comorbidities in the uremic group (3.0 &#177; 1.4) was significantly higher than in the control group (1.4 &#177; 1.2) (P &lt; 0.001, t-test).</p><p>Although the mean length of time between arrival in emergency department (ED) and surgery in the uremic group (4 &#177; 3.9 days) was greater than in the control group (2.7 &#177; 2.7 days), there was no statistical difference (P = 0.136, Mann-Whitney U-test). Preoperatively, the hemoglobin level was significantly lower in the uremic group (10.3 &#177; 1.3 mg/dL) than in the control group (11.8 &#177; 2.0 mg/dL) (P &lt; 0.001, t-test), as was the platelet count (152.9 &#177; 58.4 vs. 187.5 &#177; 72.1, P = 0.032, t-test).</p><p><xref ref-type="table" rid="table4">Table 4</xref> shows postoperative results. The comparison of the number of units of PRBC and FFP transfused revealed a statistical difference (P &lt; 0.001, Mann-Whitney U-test). Analysis of the variables revealed that there were significantly higher complication rate in the uremic group than in the control group (13/21 vs. 61/309) (P &lt; 0.001, chi-square test). However, there was no significant difference when comparing the surgery-related complications between the two</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Complications within 12 months of surgery in the uremic group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Time of Complication</th><th align="center" valign="middle" >Fracture location</th><th align="center" valign="middle" >Type of Surgery</th><th align="center" valign="middle" >Complication</th><th align="center" valign="middle" >Management</th></tr></thead><tr><td align="center" valign="middle" >During admission</td><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Hemiarthroplasty</td><td align="center" valign="middle" >Acute myocardial infarction</td><td align="center" valign="middle" >Coronary artery bypass surgery</td></tr><tr><td align="center" valign="middle"  rowspan="2"  ></td><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Hemiarthroplasty</td><td align="center" valign="middle" >A-V fistula occlusion</td><td align="center" valign="middle" >Surgical thrombectomy</td></tr><tr><td align="center" valign="middle" >IT</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >A-V fistula occlusion</td><td align="center" valign="middle" >Surgical thrombectomy</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Within 30 days</td><td align="center" valign="middle" >IT</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >A-V fistula occlusion</td><td align="center" valign="middle" >Surgical thrombectomy</td></tr><tr><td align="center" valign="middle" >IT</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >Surgical thrombectomy</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Hemiarthroplasty</td><td align="center" valign="middle" >Peptic ulcer with bleeding</td><td align="center" valign="middle" >Endoscopic treatment</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >IT</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >Heart failure</td><td align="center" valign="middle" >Medication control</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >Hepatic encephalopathy</td><td align="center" valign="middle" >Medication control</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Hemiarthroplasty</td><td align="center" valign="middle" >Contralateral femoral neck fracture</td><td align="center" valign="middle" >Bipolar arthroplasty</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Within 12 months</td><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >Implant failure</td><td align="center" valign="middle" >Bipolar arthroplasty</td></tr><tr><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >Implant failure</td><td align="center" valign="middle" >Total hip arthroplasty</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >FN</td><td align="center" valign="middle" >Hemiathroplasty</td><td align="center" valign="middle" >Pneumonia</td><td align="center" valign="middle" >Intubation with ventilator support (patient died)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >IT</td><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >Peripheral artery occlusion</td><td align="center" valign="middle" >Amputation</td></tr></tbody></table></table-wrap><p>FN: Femoral neck; IT: Intertrochanteric area; A-V fistula: arteriovenous fistula.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Demographics of the uremic and control patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Uremic group (n = 21)</th><th align="center" valign="middle" >Control group (n = 309)</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Age (years)</td><td align="center" valign="middle" >69.9 &#177; 8.5</td><td align="center" valign="middle" >78.7 &#177; 10.5</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Sex (M: F)</td><td align="center" valign="middle" >6: 15</td><td align="center" valign="middle" >114: 195</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Number of comorbidities (n)</td><td align="center" valign="middle" >3.0 &#177; 1.4</td><td align="center" valign="middle" >1.4 &#177; 1.2</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Cardiovascular disease</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >122</td><td align="center" valign="middle" >0.005</td></tr><tr><td align="center" valign="middle" >Diabetes mellitus</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >0.007</td></tr><tr><td align="center" valign="middle" >Hepatitis</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >0.025</td></tr><tr><td align="center" valign="middle" >COPD</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Peptic ulcer</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Cancer</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Cerebrovascular accident</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >59</td><td align="center" valign="middle" >0.776</td></tr><tr><td align="center" valign="middle" >ESRD</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Fracture location (n)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.563</td></tr><tr><td align="center" valign="middle" >Intracapsular femoral neck</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >142</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Intertrochanteric area</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >157</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Type of surgery (n)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.448</td></tr><tr><td align="center" valign="middle" >Osteosynthesis</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >180</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Prosthesis replacement</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >129</td><td align="center" valign="middle" >-</td></tr></tbody></table></table-wrap><p>COPD: chronic obstructive pulmonary disease; ESRD: end-stage renal disease. *Statistical significance, t-test.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Perioperative factors in the uremic and control patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Uremic group (n = 21)</th><th align="center" valign="middle" >Control group (n = 309)</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Time from ED to surgery (days)</td><td align="center" valign="middle" >4 &#177; 3.9</td><td align="center" valign="middle" >2.7 &#177; 2.7</td><td align="center" valign="middle" >0.136</td></tr><tr><td align="center" valign="middle" >Blood test</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >White blood cell count (u/mL)</td><td align="center" valign="middle" >9857.1 &#177; 3894.7</td><td align="center" valign="middle" >10,514.9 &#177; 3731.9</td><td align="center" valign="middle" >0.436</td></tr><tr><td align="center" valign="middle" >Hemoglobin (mg/dL)</td><td align="center" valign="middle" >10.3 &#177; 1.3</td><td align="center" valign="middle" >11.8 &#177; 2.0</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Platelet count</td><td align="center" valign="middle" >152.9 &#177; 58.4</td><td align="center" valign="middle" >187.5 &#177; 72.1</td><td align="center" valign="middle" >0.032*</td></tr><tr><td align="center" valign="middle" >INR</td><td align="center" valign="middle" >1.1 &#177; 0.1</td><td align="center" valign="middle" >1.1 &#177; 1.2</td><td align="center" valign="middle" >0.95</td></tr><tr><td align="center" valign="middle" >BUN (mg/dL)</td><td align="center" valign="middle" >48.1 &#177; 27.8</td><td align="center" valign="middle" >21.5 &#177; 12.9</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >Cr (mg/dL)</td><td align="center" valign="middle" >5.8 &#177; 2.1</td><td align="center" valign="middle" >1.1 &#177; 0.9</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >eCCr</td><td align="center" valign="middle" >9.3 &#177; 4.5</td><td align="center" valign="middle" >70.3 &#177; 47.3</td><td align="center" valign="middle" >&lt;0.001*</td></tr><tr><td align="center" valign="middle" >ASA classification</td><td align="center" valign="middle" >3.1 &#177; 1.2</td><td align="center" valign="middle" >2.9 &#177; 0.3</td><td align="center" valign="middle" >0.104</td></tr></tbody></table></table-wrap><p>ED: emergency department; INR: international normalized ratio; BUN: blood urea nitrogen. Cr: creatinine; eCCr: estimated creatinine clearance rate; ASA: American Society of Anesthesiologists. *Statistical significance, t-test.</p><p>groups (P = 0.127, chi square test).</p></sec><sec id="s4"><title>4. Discussion</title><p>According to data from the US Renal Data System and the Taiwan National</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Postoperative factors in the uremic and control patients</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Uremic group (n = 21)</th><th align="center" valign="middle" >Control group (n = 309)</th><th align="center" valign="middle" >P-value</th></tr></thead><tr><td align="center" valign="middle" >Total blood loss (mL)</td><td align="center" valign="middle" >138.2 &#177; 98.3</td><td align="center" valign="middle" >181.6 &#177; 124.8</td><td align="center" valign="middle" >0.120</td></tr><tr><td align="center" valign="middle" >Blood transfusion (units)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Packed red blood cell</td><td align="center" valign="middle" >0.7 &#177; 0.9</td><td align="center" valign="middle" >0.6 &#177; 1.0</td><td align="center" valign="middle" >&lt;0.001<sup>†</sup></td></tr><tr><td align="center" valign="middle" >Fresh frozen plasma</td><td align="center" valign="middle" >0.2 &#177; 0.6</td><td align="center" valign="middle" >0.1 &#177; 0.6</td><td align="center" valign="middle" >&lt;0.001<sup>†</sup></td></tr><tr><td align="center" valign="middle" >Duration of antibiotics use (days)</td><td align="center" valign="middle" >2.1 &#177; 1.4</td><td align="center" valign="middle" >2.5 &#177; 2.1</td><td align="center" valign="middle" >0.316</td></tr><tr><td align="center" valign="middle" >Admission length (days)</td><td align="center" valign="middle" >11.1 &#177; 7.6</td><td align="center" valign="middle" >9.5 &#177; 4.6</td><td align="center" valign="middle" >0.139</td></tr><tr><td align="center" valign="middle" >Complications (n)</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >0.001*</td></tr><tr><td align="center" valign="middle" >In hospital</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >0.389</td></tr><tr><td align="center" valign="middle" >Within 30 days</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >0.008*</td></tr><tr><td align="center" valign="middle" >Within 12 months</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.019*</td></tr><tr><td align="center" valign="middle" >Surgery-related</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.127</td></tr><tr><td align="center" valign="middle" >In hospital Mortality</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >1.000</td></tr><tr><td align="center" valign="middle" >Re do surgery (n)</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >0.128</td></tr></tbody></table></table-wrap><p>*Statistical significance, t-test.</p><p>Health Insurance Research Database, Taiwan has the greatest incidence and the second highest prevalence of ESRD in the world since 2000 [<xref ref-type="bibr" rid="scirp.82586-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref18">18</xref>] . Recent advances in hemodialysis have improved the life expectancy and quality of life of ESRD patients. In addition, the advancements in anesthesia, orthopedic implants, and surgical techniques have made elective orthopedic surgery safer in uremic patients [<xref ref-type="bibr" rid="scirp.82586-ref19">19</xref>] . However, for unanticipated surgery such as hip fracture repair, the outcomes remain unpredictable. Hip fractures have been shown to be strongly related to ESRD and long-term dialysis [<xref ref-type="bibr" rid="scirp.82586-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref16">16</xref>] . Unexpected surgery, surgery without adequate medical optimization, and poor medical condition at the time of surgery are all causes of higher morbidity and mortality in uremic patients who need non-routine orthopedic surgery. A similar situation is seen in geriatric hip fractures. Hip fractures in the geriatric population have become common and result in significant morbidity, mortality, and medical costs [<xref ref-type="bibr" rid="scirp.82586-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref20">20</xref>] . The current study compares and perioperative and postoperative results between these two populations with similar incidence of hip fracture.</p><p>The statistical analysis in the current study showed that patients in the uremic group were significantly younger than those in the control group. For our cohort, the number of days between arriving at the ED and having surgery was not significantly higher in the uremic group than in the control group. Each patient underwent a routine cardiac survey before surgery. During the routine cardiac echocardiography examination, every uremia patient was noted to have moderate to severe cardiac pathology including ventricular wall thickening, arrhythmias, valve disorders, and pulmonary hypertension. The presence of underlying cardiac pathology is an important consideration when counseling patients, relatives and caregivers about the risks of anesthesia and surgery.</p><p>Of the 13 complications noted in the uremic patient group, only two were directly related to the hip fracture surgery, and both occurred in two patients with femoral neck fractures. Osteosynthesis surgery for femoral neck fracture in uremic patients undergoing maintenance hemodialysis remains controversial. Fixation with metallic devices has the advantage of being less invasive, with a shorter of operation time, while prosthesis replacement surgery allows weight- bearing ambulation immediately. Evidence shows that femoral neck fractures in uremic patients that are treated with osteosynthesis surgery, utilizing either percutaneous screws or hip compression plate fixation, have poor functional results and a high rate of complications including infection, nonunion, and osteonecrosis [<xref ref-type="bibr" rid="scirp.82586-ref21">21</xref>] . In our study, there were 11 patients with femoral neck fractures, and 3 received percutaneous screws fixations. Two of the three fixations performed failed, requiring revised hip prosthesis replacement surgery. The failure rate of osteosynthesis surgery was 66.7%. Only one complication (pneumonia and sepsis) occurred in the prosthesis replacement group of eight patients, although this complication led to the patient’s death within the 12-month follow-up period. The death was not directly related to prosthesis failure. Our high failure rate following osteosynthesis surgery for femoral neck fractures in uremic patients is comparable to that reported in the literature [<xref ref-type="bibr" rid="scirp.82586-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref22">22</xref>] . In light of this finding, prosthesis replacement surgery may be the optimal choice of operation for femoral neck fractures in uremic patients, including valgus-impaction fractures and non-displaced fractures.</p><p>In comparison there is relative consensus regarding the treatment for intertrochanteric fracture of the femur in uremic patients [<xref ref-type="bibr" rid="scirp.82586-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref11">11</xref>] . As femoral intertrochanteric fracture is considered an extracapsular fracture of the proximal femur, fracture healing is more reliable than that in case of femoral neck fracture after osteosynthesis surgery. In our study, 10 uremic patients with intertrochanteric fracture underwent hip compression screw fixation. Four complications were noted (three patients with arteriovenous fistula failure and one patient with acute heart failure) within 30 days postoperatively; however, no complication was directly associated with osteosynthesis surgery. All fractures were united at a mean time of 11 months yielding a fracture union rate of 100%. We therefore recommend osteosynthesis surgery for repair of femoral intertrochanteric fracture in uremic patients given this high rate success observed after appropriate medical optimization.</p><p>There were two surgery-related complications (implant failure) in the uremic group (9.5%) and eight complications (six patients with implant failure and two with surgical site infection) in the control group (2.6%). Statistical analysis revealed no significant difference in the rate of surgery-related complications. Additionally, the incidence of surgery-related complications for both groups in the current study was similar to that reported in the literature [<xref ref-type="bibr" rid="scirp.82586-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.82586-ref23">23</xref>] . The current study also found that the postoperative complication rate was significantly higher in the uremic patients with hip fractures than in the geriatric population. We concluded that the major complications for both the uremic patients and geriatric patients after hip surgery are a result of their medical comorbidities. To our knowledge, this report is the first study to compare postoperative and perioperative results between these two patient groups.</p><p>Two uremic patients experienced arteriovenous (A-V) fistula occlusion during their first postoperative hemodialysis treatment. The A-V fistula is the route through which hemodialysis is performed. This treatment is crucial in uremic patients for removing toxins, balancing acid-base status, and normalizing electrolytes, especially after anesthesia and surgical procedures. A failed first renal replacement therapy in these patients may complicate the postoperative situation, and lead to further morbidity and mortality. An emergency embolectomy or thrombectomy was performed for both occluded fistulas, and the patients underwent hemodialysis on the same day. Fortunately, there were no further complications.</p><p>We made efforts to limit any bias between the two groups. However, this study has limitations. First, the current study was a retrospective study. Normally, the surgeons and anesthesiologists treat patients conservatively if the risks of surgery and anesthesia are too high. In fact, four patients in the uremic group were treated conservatively, and three died due to their compromised cardiopulmonary condition during admission. This selection bias may have affected the outcomes of our analysis. Second, the analysis included all the selected patients without further stratification. Further studies should distinguish the osteosynthesis group from the prosthesis replacement group. Finally, there were several orthopedic surgeons performing the operations. Although all the surgeons were trained and all worked in the same institute, there were some differences in their surgical technique, approach, and preference regarding the use of implant or prosthesis.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Although uremic patients are often younger than patients with osteoporosis related hip fractures, anesthesia and surgery carry increased risk for them. Preoperatively, medical optimization is required, and postoperatively, aggressive care should be provided for all complications. For femoral neck fracture in uremic patients, prosthesis replacement surgery may lessen the rate of implant failure, while osteosynthesis surgery for intertrochanteric fractures in the same population has a high fracture union rate. Despite thorough preoperative medical optimization, careful evaluation of operative indication, and intensive postoperative medical care, higher rates of complications are likely to occur due to uremic patients’ medical comorbidities.</p></sec><sec id="s6"><title>Acknowledgements</title><p>The authors would like to Miss Shu-Hua Huang for data collection and performing statistical analysis.</p></sec><sec id="s7"><title>Conflict of Interests</title><p>Yi-Hsun Yu, Yung-Heng Hsu, Ying-Chao Chou, I-Chuan Tseng, Wen-Lin Yeh, Chi-Chung Wu declare that they have no conflict of interest.</p></sec><sec id="s8"><title>Compliance with Ethical Requirements</title><p>For this type of study, formal consent is not required.</p></sec><sec id="s9"><title>Cite this paper</title><p>Yu, Y.-H., Hsu, Y.-H., Chou, Y.-C., Tseng, I.-C., Yeh, W.-L. and Wu, C.-C. (2018) Higher Complication Rate Following Hip Fractures in Uremic Patients Undergoing Maintenance Hemo- dialysis: A Cohort Study. Open Access Library Journal, 5: e3986. https://doi.org/10.4236/oalib.1103986</p></sec></body><back><ref-list><title>References</title><ref id="scirp.82586-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Coco, M. and Rush, H. (2000) Increased Incidence of Hip Fractures in Dialysis Patients with Low Serum Parathyroid Hormone. American Journal of Kidney Diseases, 36, 1115-1121. https://doi.org/10.1053/ajkd.2000.19812</mixed-citation></ref><ref id="scirp.82586-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ball, A.M., Gillen, D.L., Sherrard, D., Weiss, N.S., Emerson, S.S., Seliger, S.L., Kestenbaum, B.R. and Stehman-Breen, C. (2002) Risk of Hip Fracture among Dialysis and Renal Transplant Recipients. JAMA, 288, 3014-3018.https://doi.org/10.1001/jama.288.23.3014</mixed-citation></ref><ref id="scirp.82586-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Chen, Y.J., Kung, P.T., Wang, Y.H., Huang, C.C., Hsu, S.C., Tsai, W.C. and Hsu, H.C. (2014) Greater Risk of Hip Fracture in Hemodialysis than in Peritoneal Dialysis. Osteoporosis International, 25, 1513-1518. https://doi.org/10.1007/s00198-014-2632-6</mixed-citation></ref><ref id="scirp.82586-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Picton, M.L., Moore, P.R., Mawer, E.B., Houghton, D., Freemont, A.J., Hutchison, A.J., Gokal, R. and Hoyland, J.A. (2000) Down-Regulation of Human Osteoblast PTH/PTHrP Receptor mRNA in End-Stage Renal Failure. Kidney International, 58, 1440-1449. https://doi.org/10.1046/j.1523-1755.2000.00306.x</mixed-citation></ref><ref id="scirp.82586-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Alem, A.M., Sherrard, D.J., Gillen, D.L., Weiss, N.S., Beresford, S.A., Heckbert, S.R., Wong, C. and Stehman-Breen, C. (2000) Increased Risk of Hip Fracture among Patients with End-Stage Renal Disease. Kidney International, 58, 396-399.https://doi.org/10.1046/j.1523-1755.2000.00178.x</mixed-citation></ref><ref id="scirp.82586-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Arneson, T.J., Li, S., Liu, J., Kilpatrick, R.D., Newsome, B.B. and St Peter, W.L. (2013) Trends in Hip Fracture Rates in US Hemodialysis Patients, 1993-2010. American Journal of Kidney Diseases, 62, 747-754.https://doi.org/10.1053/j.ajkd.2013.02.368</mixed-citation></ref><ref id="scirp.82586-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Nickolas, T.L., McMahon, D.J. and Shane, E. (2006) Relationship between Moderate to Severe Kidney Disease and Hip Fracture in the United States. Journal of the American Society of Nephrology, 17, 3223-3232. https://doi.org/10.1681/ASN.2005111194</mixed-citation></ref><ref id="scirp.82586-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Chang, N.T., Lee, Y.H., Hsu, J.C., Chan, C.L., Huang, G.S., Renn, J.H. and Yang, N.P. (2013) Epidemiological Study of Orthopedic Injuries in Hemodialysis Patients in Taiwan: A Fixed Cohort Survey, 2004-2008. Clinical Interventions in Aging, 8, 301-308. https://doi.org/10.2147/CIA.S41132</mixed-citation></ref><ref id="scirp.82586-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Tentori, F., McCullough, K., Kilpatrick, R.D., Bradbury, B.D., Robinson, B.M., Kerr, P.G. and Pisoni, R.L. (2014) High Rates of Death and Hospitalization Follow Bone Fracture among Hemodialysis Patients. Kidney International, 85, 166-173.https://doi.org/10.1038/ki.2013.279</mixed-citation></ref><ref id="scirp.82586-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Karaeminogullari, O., Demirors, H., Sahin, O., Ozalay, M., Ozdemir, N. and Tandogan, R.N. (2007) Analysis of Outcomes for Surgically Treated Hip Fractures in Patients Undergoing Chronic Hemodialysis. Journal of Bone and Joint Surgery, 89, 324-331.</mixed-citation></ref><ref id="scirp.82586-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Tosun, B., Atmaca, H. and Gok, U. (2010) Operative Treatment of Hip Fractures in Patients Receiving Hemodialysis. Musculoskeletal Surgery, 94, 71-75. https://doi.org/10.1007/s12306-010-0080-9</mixed-citation></ref><ref id="scirp.82586-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Vaughn, J., Cohen, E., Vopat, B.G., Kane, P., Abbood, E. and Born, C. (2015) Complications of Short versus Long Cephalomedullary Nail for Intertrochanteric Femur Fractures, Minimum 1-Year Follow-Up. European Journal of Orthopaedic Surgery &amp; Traumatology, 25, 665-670. https://doi.org/10.1007/s00590-014-1557-2</mixed-citation></ref><ref id="scirp.82586-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ha, Y.C., Baek, J.H., Ko, Y.B., Park, S.M. and Song, S.H. (2015) High Mortality and Poor Morbidity after Hip Fractures in Patients with Previous Vertebral Fractures. Journal of Bone and Mineral Metabolism, 33, 547-552. https://doi.org/10.1007/s00774-014-0616-4</mixed-citation></ref><ref id="scirp.82586-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Carpintero, P., Caeiro, J.R., Carpintero, R., Morales, A., Silva, S. and Mesa, M. (2014) Complications of Hip Fractures: A Review. World Journal of Orthopedics, 5, 402-411. https://doi.org/10.5312/wjo.v5.i4.402</mixed-citation></ref><ref id="scirp.82586-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Liu, Y., Peng, M., Lin, L., Liu, X., Qin, Y. and Hou, X. (2015) Relationship between American Society of Anesthesiologists (ASA) Grade and 1-Year Mortality in Nonagenarians under Hip Fracture Surgery. Osteoporosis International, 26, 1029-1033. https://doi.org/10.1007/s00198-014-2931-y</mixed-citation></ref><ref id="scirp.82586-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Lin, Z.Z., Wan, J.J., Chung, C.R., Huang, P.C., Su, B.A., Cheng, K.C., Chio, C.C. and Chien, C.C. (2014) Epidemiology and Mortality of Hip Fracture among Patients on Hemodialysis: Taiwan National Cohort Study. Bone, 64, 235-239. https://doi.org/10.1016/j.bone.2014.04.017</mixed-citation></ref><ref id="scirp.82586-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">US Renal Data System (2005) USRDS 2005 Annual Data Report. The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda.</mixed-citation></ref><ref id="scirp.82586-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Yang, W.C. and Hwang, S.J. (2008) Taiwan Society of Nephrology. Incidence, Prevalence and Mortality Trends of Dialysis End-Stage Renal Disease in Taiwan from 1990 to 2001: The Impact of National Health Insurance. Nephrology Dialysis Transplantation, 23, 3977-3982. https://doi.org/10.1093/ndt/gfn406</mixed-citation></ref><ref id="scirp.82586-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Yu, Y.H., Chen, W.J., Chen, L.H., Niu, C.C., Fu, T.S. and Lai, P.L. (2011) Posterior Instrumented Lumbar Spinal Surgery in Uremic Patients under Maintenance Hemodialysis. Spine, 36, 660-666. https://doi.org/10.1097/BRS.0b013e3181dc9a33</mixed-citation></ref><ref id="scirp.82586-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Konstantinidis, L., Papaioannou, C., Blanke, P., Hirschmüller, A., Südkamp, N.P. and Helwig, P. (2013) Failure after Osteosynthesis of Trochanteric Fractures. Where Is the Limit of Osteoporosis? Osteoporosis International, 24, 2701-2706. https://doi.org/10.1007/s00198-013-2392-8</mixed-citation></ref><ref id="scirp.82586-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Roden, M., Schon, M. and Fredin, H. (2003) Treatment of Displaced Femoral Neck Fractures: A Randomized Minimum 5-Year Follow Up Study of Screws and Bipolar Hemiprostheses in 100 Patients. Acta Orthopaedica Scandinavica, 74, 42-44. https://doi.org/10.1080/00016470310013635</mixed-citation></ref><ref id="scirp.82586-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Haidukewych, G.J., Rothwell, W.S., Jacofsky, D.J., Torchia, M.E. and Berry, D.J. (2004) Operative Treatment of Femoral Neck Fractures in Patients between the Ages of Fifteen and Fifty Years. The Journal of Bone and Joint Surgery. American Volume, 86, 1711-1716. https://doi.org/10.2106/00004623-200408000-00015</mixed-citation></ref><ref id="scirp.82586-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Lorich, D.G., Geller, D.S. and Nielson, J.H. (2004) Osteoporotic Pertrochanteric Hip Fractures: Management and Current Controversies. Instructional Course Lectures, 53, 441-454. https://doi.org/10.2106/00004623-200402000-00028</mixed-citation></ref></ref-list></back></article>